Balugrastim (Neugranin) in Breast Cancer Participants Receiving Doxorubicin/Docetaxel

NCT00837265 · clinicaltrials.gov ↗

PHASE2,PHASE3

Phase

COMPLETED

Status

334

Enrollment

INDUSTRY

Sponsor class

Conditions

Chemotherapy-induced Neutropenia

Interventions

BIOLOGICAL: Balugrastim
DRUG: Pegfilgrastim
DRUG: Chemotherapy Regimen

Sponsor

Teva Branded Pharmaceutical Products R&D, Inc.